Charles River Laboratories International, Inc.
Ariel sees Charles River benefiting from early signs of a recovery in biopharmaceutical research and development spending. Stronger bookings in Discovery & Safety Assessment and…
Ariel Mid Cap Value Composite is a managed-account equity strategy of Ariel Investments LLC. It invests in mid-sized companies with sustainable competitive advantages, solid balance sheets and long-term earnings power not fully reflected in share prices. The representative portfolio has fewer holdings and greater sector concentration than its benchmarks.
Ariel sees Charles River benefiting from early signs of a recovery in biopharmaceutical research and development spending. Stronger bookings in Discovery & Safety Assessment and…
Ariel expects Haemonetics to sustain growth on the back of its strengthening plasma franchise. Results and full-year guidance exceeded expectations as plasma growth accelerated…
Ariel believes Bio-Rad's operational restructuring and capital allocation can unlock long-term earnings growth. Organic sales and margin performance exceeded expectations despite…
Ariel maintains a constructive longer-term view on Norwegian Cruise Line despite weak yield expectations and choppy bookings. Demand for European itineraries has softened and…
Ariel views OneSpaWorld's share-price weakness as profit-taking rather than a change in its business quality. Results and guidance improved on robust cruise passenger spending…
Ariel thinks the market is underestimating Middleby's recovery after two consecutive quarters of healthy organic growth. Demand is improving in quick-service restaurant…
Ariel acquired ADI following its spin-off from Resideo, attracted by an industry-leading distribution network. ADI benefits from scale across security, audio-visual and fire and…
Source PDFs are not republished here; only extracted ideas and quotes.